                               SEQUENCE LISTING

<110> BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
 
<120> ENGINEERED T CELL RECEPTORS AND METHODS OF USE

<130> MDAC.P1220WO

<140> PCT/US2021/032818
<141> 2021-05-17

<150> 63/026,445
<151> 2020-05-18

<160> 36    

<170> PatentIn version 3.5

<210> 1
<211> 810
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 1
atgaggcaag tggcgagagt gatcgtgttc ctgaccctga gtactttgag ccttgctaag       60

accacccagc ccatctccat ggactcatat gaaggacaag aagtgaacat aacctgtagc      120

cacaacaaca ttgctacaaa tgattatatc acgtggtacc aacagtttcc cagccaagga      180

ccacgattta ttattcaagg atacaagaca aaagttacaa acgaagtggc ctccctgttt      240

atccctgccg acagaaagtc cagcactctg agcctgcccc gggtttccct gagcgacact      300

gctgtgtact actgcctcgt ggtcgagggg aacagagatg acaagatcat ctttggaaaa      360

gggacacgac ttcatattct ccccaatatc cagaaccctg accctgccgt gtaccagctg      420

agagactcta aatccagtga caagtctgtc tgcctattca ccgattttga ttctcaaaca      480

aatgtgtcac aaagtaagga ttctgatgtg tatatcacag acaaaactgt gctagacatg      540

aggtctatgg acttcaagag caacagtgct gtggcctgga gcaacaaatc tgactttgca      600

tgtgcaaacg ccttcaacaa cagcattatt ccagaagaca ccttcttccc cagcccagaa      660

agttcctgtg atgtcaagct ggtcgagaaa agctttgaaa cagatacgaa cctaaacttt      720

caaaacctgt cagtgattgg gttccgaatc ctcctcctga aagtggccgg gtttaatctg      780

ctcatgacgc tgcggctgtg gtccagctaa                                       810


<210> 2
<211> 933
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 2
atgagcctcg ggctcctgtg ctgtggggcc ttttctctcc tgtgggcagg tccagtgaat       60

gctggtgtca ctcagacccc aaaattccgg gtcctgaaga caggacagag catgacactg      120

ctgtgtgccc aggatatgaa ccatgaatac atgtactggt atcgacaaga cccaggcatg      180

gggctgaggc tgattcatta ctcagttggt gagggtacaa ctgccaaagg agaggtccct      240

gatggctaca atgtctccag attaaaaaaa cagaatttcc tgctggggtt ggagtcggct      300

gctccctccc aaacatctgt gtacttctgt gccagccccc caacgccctc ctcctacaat      360

gagcagttct tcgggccagg gacacggctc accgtgctag aggacctgaa aaacgtgttc      420

ccacccgagg tcgctgtgtt tgagccatca gaagcagaga tctcccacac ccaaaaggcc      480

acactggtgt gcctggccac aggcttcttc cctgaccacg tggagctgag ctggtgggtg      540

aatgggaagg aggtgcacag tggggtcagc acggacccgc agcccctcaa ggagcagccc      600

gccctcaatg actccagata ctgcctgagc agccgcctga gggtctcggc caccttctgg      660

cagaaccccc gcaaccactt ccgctgtcaa gtccagttct acgggctctc ggagaatgac      720

gagtggaccc aggatagggc caaacccgtc acccagatcg tcagcgccga ggcctggggt      780

agagcagact gtggctttac ctcggtgtcc taccagcaag gggtcctgtc tgccaccatc      840

ctctatgaga tcctgctagg gaaggccacc ctgtatgctg tgctggtcag cgcccttgtg      900

ttgatggcca tggtcaagag aaaggatttc taa                                   933


<210> 3
<211> 269
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 3
Met Arg Gln Val Ala Arg Val Ile Val Phe Leu Thr Leu Ser Thr Leu 
1               5                   10                  15      


Ser Leu Ala Lys Thr Thr Gln Pro Ile Ser Met Asp Ser Tyr Glu Gly 
            20                  25                  30          


Gln Glu Val Asn Ile Thr Cys Ser His Asn Asn Ile Ala Thr Asn Asp 
        35                  40                  45              


Tyr Ile Thr Trp Tyr Gln Gln Phe Pro Ser Gln Gly Pro Arg Phe Ile 
    50                  55                  60                  


Ile Gln Gly Tyr Lys Thr Lys Val Thr Asn Glu Val Ala Ser Leu Phe 
65                  70                  75                  80  


Ile Pro Ala Asp Arg Lys Ser Ser Thr Leu Ser Leu Pro Arg Val Ser 
                85                  90                  95      


Leu Ser Asp Thr Ala Val Tyr Tyr Cys Leu Val Val Glu Gly Asn Arg 
            100                 105                 110         


Asp Asp Lys Ile Ile Phe Gly Lys Gly Thr Arg Leu His Ile Leu Pro 
        115                 120                 125             


Asn Ile Gln Asn Pro Asp Pro Ala Val Tyr Gln Leu Arg Asp Ser Lys 
    130                 135                 140                 


Ser Ser Asp Lys Ser Val Cys Leu Phe Thr Asp Phe Asp Ser Gln Thr 
145                 150                 155                 160 


Asn Val Ser Gln Ser Lys Asp Ser Asp Val Tyr Ile Thr Asp Lys Thr 
                165                 170                 175     


Val Leu Asp Met Arg Ser Met Asp Phe Lys Ser Asn Ser Ala Val Ala 
            180                 185                 190         


Trp Ser Asn Lys Ser Asp Phe Ala Cys Ala Asn Ala Phe Asn Asn Ser 
        195                 200                 205             


Ile Ile Pro Glu Asp Thr Phe Phe Pro Ser Pro Glu Ser Ser Cys Asp 
    210                 215                 220                 


Val Lys Leu Val Glu Lys Ser Phe Glu Thr Asp Thr Asn Leu Asn Phe 
225                 230                 235                 240 


Gln Asn Leu Ser Val Ile Gly Phe Arg Ile Leu Leu Leu Lys Val Ala 
                245                 250                 255     


Gly Phe Asn Leu Leu Met Thr Leu Arg Leu Trp Ser Ser 
            260                 265                 


<210> 4
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Met Arg Gln Val Ala Arg Val Ile Val Phe Leu Thr Leu Ser Thr Leu 
1               5                   10                  15      


Ser 
    


<210> 5
<211> 111
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 5
Leu Ala Lys Thr Thr Gln Pro Ile Ser Met Asp Ser Tyr Glu Gly Gln 
1               5                   10                  15      


Glu Val Asn Ile Thr Cys Ser His Asn Asn Ile Ala Thr Asn Asp Tyr 
            20                  25                  30          


Ile Thr Trp Tyr Gln Gln Phe Pro Ser Gln Gly Pro Arg Phe Ile Ile 
        35                  40                  45              


Gln Gly Tyr Lys Thr Lys Val Thr Asn Glu Val Ala Ser Leu Phe Ile 
    50                  55                  60                  


Pro Ala Asp Arg Lys Ser Ser Thr Leu Ser Leu Pro Arg Val Ser Leu 
65                  70                  75                  80  


Ser Asp Thr Ala Val Tyr Tyr Cys Leu Val Val Glu Gly Asn Arg Asp 
                85                  90                  95      


Asp Lys Ile Ile Phe Gly Lys Gly Thr Arg Leu His Ile Leu Pro 
            100                 105                 110     


<210> 6
<211> 141
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 6
Asn Ile Gln Asn Pro Asp Pro Ala Val Tyr Gln Leu Arg Asp Ser Lys 
1               5                   10                  15      


Ser Ser Asp Lys Ser Val Cys Leu Phe Thr Asp Phe Asp Ser Gln Thr 
            20                  25                  30          


Asn Val Ser Gln Ser Lys Asp Ser Asp Val Tyr Ile Thr Asp Lys Thr 
        35                  40                  45              


Val Leu Asp Met Arg Ser Met Asp Phe Lys Ser Asn Ser Ala Val Ala 
    50                  55                  60                  


Trp Ser Asn Lys Ser Asp Phe Ala Cys Ala Asn Ala Phe Asn Asn Ser 
65                  70                  75                  80  


Ile Ile Pro Glu Asp Thr Phe Phe Pro Ser Pro Glu Ser Ser Cys Asp 
                85                  90                  95      


Val Lys Leu Val Glu Lys Ser Phe Glu Thr Asp Thr Asn Leu Asn Phe 
            100                 105                 110         


Gln Asn Leu Ser Val Ile Gly Phe Arg Ile Leu Leu Leu Lys Val Ala 
        115                 120                 125             


Gly Phe Asn Leu Leu Met Thr Leu Arg Leu Trp Ser Ser 
    130                 135                 140     


<210> 7
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Asn Ile Ala Thr Asn Asp Tyr 
1               5           


<210> 8
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Gly Tyr Lys Thr Lys 
1               5   


<210> 9
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Leu Val Val Glu Gly Asn Arg Asp Asp Lys Ile Ile 
1               5                   10          


<210> 10
<211> 310
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 10
Met Ser Leu Gly Leu Leu Cys Cys Gly Ala Phe Ser Leu Leu Trp Ala 
1               5                   10                  15      


Gly Pro Val Asn Ala Gly Val Thr Gln Thr Pro Lys Phe Arg Val Leu 
            20                  25                  30          


Lys Thr Gly Gln Ser Met Thr Leu Leu Cys Ala Gln Asp Met Asn His 
        35                  40                  45              


Glu Tyr Met Tyr Trp Tyr Arg Gln Asp Pro Gly Met Gly Leu Arg Leu 
    50                  55                  60                  


Ile His Tyr Ser Val Gly Glu Gly Thr Thr Ala Lys Gly Glu Val Pro 
65                  70                  75                  80  


Asp Gly Tyr Asn Val Ser Arg Leu Lys Lys Gln Asn Phe Leu Leu Gly 
                85                  90                  95      


Leu Glu Ser Ala Ala Pro Ser Gln Thr Ser Val Tyr Phe Cys Ala Ser 
            100                 105                 110         


Pro Pro Thr Pro Ser Ser Tyr Asn Glu Gln Phe Phe Gly Pro Gly Thr 
        115                 120                 125             


Arg Leu Thr Val Leu Glu Asp Leu Lys Asn Val Phe Pro Pro Glu Val 
    130                 135                 140                 


Ala Val Phe Glu Pro Ser Glu Ala Glu Ile Ser His Thr Gln Lys Ala 
145                 150                 155                 160 


Thr Leu Val Cys Leu Ala Thr Gly Phe Phe Pro Asp His Val Glu Leu 
                165                 170                 175     


Ser Trp Trp Val Asn Gly Lys Glu Val His Ser Gly Val Ser Thr Asp 
            180                 185                 190         


Pro Gln Pro Leu Lys Glu Gln Pro Ala Leu Asn Asp Ser Arg Tyr Cys 
        195                 200                 205             


Leu Ser Ser Arg Leu Arg Val Ser Ala Thr Phe Trp Gln Asn Pro Arg 
    210                 215                 220                 


Asn His Phe Arg Cys Gln Val Gln Phe Tyr Gly Leu Ser Glu Asn Asp 
225                 230                 235                 240 


Glu Trp Thr Gln Asp Arg Ala Lys Pro Val Thr Gln Ile Val Ser Ala 
                245                 250                 255     


Glu Ala Trp Gly Arg Ala Asp Cys Gly Phe Thr Ser Val Ser Tyr Gln 
            260                 265                 270         


Gln Gly Val Leu Ser Ala Thr Ile Leu Tyr Glu Ile Leu Leu Gly Lys 
        275                 280                 285             


Ala Thr Leu Tyr Ala Val Leu Val Ser Ala Leu Val Leu Met Ala Met 
    290                 295                 300                 


Val Lys Arg Lys Asp Phe 
305                 310 


<210> 11
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Met Ser Leu Gly Leu Leu Cys Cys Gly Ala Phe Ser Leu Leu Trp Ala 
1               5                   10                  15      


Gly Pro Val 
            


<210> 12
<211> 114
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 12
Asn Ala Gly Val Thr Gln Thr Pro Lys Phe Arg Val Leu Lys Thr Gly 
1               5                   10                  15      


Gln Ser Met Thr Leu Leu Cys Ala Gln Asp Met Asn His Glu Tyr Met 
            20                  25                  30          


Tyr Trp Tyr Arg Gln Asp Pro Gly Met Gly Leu Arg Leu Ile His Tyr 
        35                  40                  45              


Ser Val Gly Glu Gly Thr Thr Ala Lys Gly Glu Val Pro Asp Gly Tyr 
    50                  55                  60                  


Asn Val Ser Arg Leu Lys Lys Gln Asn Phe Leu Leu Gly Leu Glu Ser 
65                  70                  75                  80  


Ala Ala Pro Ser Gln Thr Ser Val Tyr Phe Cys Ala Ser Pro Pro Thr 
                85                  90                  95      


Pro Ser Ser Tyr Asn Glu Gln Phe Phe Gly Pro Gly Thr Arg Leu Thr 
            100                 105                 110         


Val Leu 
        


<210> 13
<211> 177
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 13
Glu Asp Leu Lys Asn Val Phe Pro Pro Glu Val Ala Val Phe Glu Pro 
1               5                   10                  15      


Ser Glu Ala Glu Ile Ser His Thr Gln Lys Ala Thr Leu Val Cys Leu 
            20                  25                  30          


Ala Thr Gly Phe Phe Pro Asp His Val Glu Leu Ser Trp Trp Val Asn 
        35                  40                  45              


Gly Lys Glu Val His Ser Gly Val Ser Thr Asp Pro Gln Pro Leu Lys 
    50                  55                  60                  


Glu Gln Pro Ala Leu Asn Asp Ser Arg Tyr Cys Leu Ser Ser Arg Leu 
65                  70                  75                  80  


Arg Val Ser Ala Thr Phe Trp Gln Asn Pro Arg Asn His Phe Arg Cys 
                85                  90                  95      


Gln Val Gln Phe Tyr Gly Leu Ser Glu Asn Asp Glu Trp Thr Gln Asp 
            100                 105                 110         


Arg Ala Lys Pro Val Thr Gln Ile Val Ser Ala Glu Ala Trp Gly Arg 
        115                 120                 125             


Ala Asp Cys Gly Phe Thr Ser Val Ser Tyr Gln Gln Gly Val Leu Ser 
    130                 135                 140                 


Ala Thr Ile Leu Tyr Glu Ile Leu Leu Gly Lys Ala Thr Leu Tyr Ala 
145                 150                 155                 160 


Val Leu Val Ser Ala Leu Val Leu Met Ala Met Val Lys Arg Lys Asp 
                165                 170                 175     


Phe 
    


<210> 14
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Met Asn His Glu Tyr 
1               5   


<210> 15
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Ser Val Gly Glu Gly Thr 
1               5       


<210> 16
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Ala Ser Pro Pro Thr Pro Ser Ser Tyr Asn Glu Gln Phe 
1               5                   10              


<210> 17
<211> 834
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 17
atgaagaggg agagggagat gctactcatc acatcaatgt tggtcttatg gatgcaattg       60

tcacaggtga atggacaaca ggtaatgcaa attcctcagt accagcatgt acaagaagga      120

gaggacttca ccacgtactg caattcctca actactttaa gcaatataca gtggtataag      180

caaaggcctg gtggacatcc cgtttttttg atacagttag tgaagagtgg agaagtgaag      240

aagcagaaaa gactgacatt tcagtttgga gaagcaaaaa agaacagctc cctgcacatc      300

acagccaccc agactacaga tgtaggaacc tacttctgtg cagtgggaag catggatagc      360

aactatcagt taatctgggg cgctgggacc aagctaatta taaagccaga tatccagaac      420

cctgaccctg ccgtgtacca gctgagagac tctaaatcca gtgacaagtc tgtctgccta      480

ttcaccgatt ttgattctca aacaaatgtg tcacaaagta aggattctga tgtgtatatc      540

acagacaaaa ctgtgctaga catgaggtct atggacttca agagcaacag tgctgtggcc      600

tggagcaaca aatctgactt tgcatgtgca aacgccttca acaacagcat tattccagaa      660

gacaccttct tccccagccc agaaagttcc tgtgatgtca agctggtcga gaaaagcttt      720

gaaacagata cgaacctaaa ctttcaaaac ctgtcagtga ttgggttccg aatcctcctc      780

ctgaaagtgg ccgggtttaa tctgctcatg acgctgcggc tgtggtccag ctaa            834


<210> 18
<211> 936
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 18
atgagcctcg ggctcctgtg ctgtggggcc ttttctctcc tgtgggcagg tccagtgaat       60

gctggtgtca ctcagacccc aaaattccgg gtcctgaaga caggacagag catgacactg      120

ctgtgtgccc aggatatgaa ccatgaatac atgtactggt atcgacaaga cccaggcatg      180

gggctgaggc tgattcatta ctcagttggt gagggtacaa ctgccaaagg agaggtccct      240

gatggctaca atgtctccag attaaaaaaa cagaatttcc tgctggggtt ggagtcggct      300

gctccctccc aaacatctgt gtacttctgt gccagcagcc aggaacggac ctggccctac      360

aatgagcagt tcttcgggcc agggacacgg ctcaccgtgc tagaggacct gaaaaacgtg      420

ttcccacccg aggtcgctgt gtttgagcca tcagaagcag agatctccca cacccaaaag      480

gccacactgg tgtgcctggc cacaggcttc ttccctgacc acgtggagct gagctggtgg      540

gtgaatggga aggaggtgca cagtggggtc agcacggacc cgcagcccct caaggagcag      600

cccgccctca atgactccag atactgcctg agcagccgcc tgagggtctc ggccaccttc      660

tggcagaacc cccgcaacca cttccgctgt caagtccagt tctacgggct ctcggagaat      720

gacgagtgga cccaggatag ggccaaaccc gtcacccaga tcgtcagcgc cgaggcctgg      780

ggtagagcag actgtggctt tacctcggtg tcctaccagc aaggggtcct gtctgccacc      840

atcctctatg agatcctgct agggaaggcc accctgtatg ctgtgctggt cagcgccctt      900

gtgttgatgg ccatggtcaa gagaaaggat ttctaa                                936


<210> 19
<211> 277
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 19
Met Lys Arg Glu Arg Glu Met Leu Leu Ile Thr Ser Met Leu Val Leu 
1               5                   10                  15      


Trp Met Gln Leu Ser Gln Val Asn Gly Gln Gln Val Met Gln Ile Pro 
            20                  25                  30          


Gln Tyr Gln His Val Gln Glu Gly Glu Asp Phe Thr Thr Tyr Cys Asn 
        35                  40                  45              


Ser Ser Thr Thr Leu Ser Asn Ile Gln Trp Tyr Lys Gln Arg Pro Gly 
    50                  55                  60                  


Gly His Pro Val Phe Leu Ile Gln Leu Val Lys Ser Gly Glu Val Lys 
65                  70                  75                  80  


Lys Gln Lys Arg Leu Thr Phe Gln Phe Gly Glu Ala Lys Lys Asn Ser 
                85                  90                  95      


Ser Leu His Ile Thr Ala Thr Gln Thr Thr Asp Val Gly Thr Tyr Phe 
            100                 105                 110         


Cys Ala Val Gly Ser Met Asp Ser Asn Tyr Gln Leu Ile Trp Gly Ala 
        115                 120                 125             


Gly Thr Lys Leu Ile Ile Lys Pro Asp Ile Gln Asn Pro Asp Pro Ala 
    130                 135                 140                 


Val Tyr Gln Leu Arg Asp Ser Lys Ser Ser Asp Lys Ser Val Cys Leu 
145                 150                 155                 160 


Phe Thr Asp Phe Asp Ser Gln Thr Asn Val Ser Gln Ser Lys Asp Ser 
                165                 170                 175     


Asp Val Tyr Ile Thr Asp Lys Thr Val Leu Asp Met Arg Ser Met Asp 
            180                 185                 190         


Phe Lys Ser Asn Ser Ala Val Ala Trp Ser Asn Lys Ser Asp Phe Ala 
        195                 200                 205             


Cys Ala Asn Ala Phe Asn Asn Ser Ile Ile Pro Glu Asp Thr Phe Phe 
    210                 215                 220                 


Pro Ser Pro Glu Ser Ser Cys Asp Val Lys Leu Val Glu Lys Ser Phe 
225                 230                 235                 240 


Glu Thr Asp Thr Asn Leu Asn Phe Gln Asn Leu Ser Val Ile Gly Phe 
                245                 250                 255     


Arg Ile Leu Leu Leu Lys Val Ala Gly Phe Asn Leu Leu Met Thr Leu 
            260                 265                 270         


Arg Leu Trp Ser Ser 
        275         


<210> 20
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 20
Met Lys Arg Glu Arg Glu Met Leu Leu Ile Thr Ser Met Leu Val Leu 
1               5                   10                  15      


Trp Met Gln Leu Ser Gln Val Asn 
            20                  


<210> 21
<211> 112
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 21
Gly Gln Gln Val Met Gln Ile Pro Gln Tyr Gln His Val Gln Glu Gly 
1               5                   10                  15      


Glu Asp Phe Thr Thr Tyr Cys Asn Ser Ser Thr Thr Leu Ser Asn Ile 
            20                  25                  30          


Gln Trp Tyr Lys Gln Arg Pro Gly Gly His Pro Val Phe Leu Ile Gln 
        35                  40                  45              


Leu Val Lys Ser Gly Glu Val Lys Lys Gln Lys Arg Leu Thr Phe Gln 
    50                  55                  60                  


Phe Gly Glu Ala Lys Lys Asn Ser Ser Leu His Ile Thr Ala Thr Gln 
65                  70                  75                  80  


Thr Thr Asp Val Gly Thr Tyr Phe Cys Ala Val Gly Ser Met Asp Ser 
                85                  90                  95      


Asn Tyr Gln Leu Ile Trp Gly Ala Gly Thr Lys Leu Ile Ile Lys Pro 
            100                 105                 110         


<210> 22
<211> 141
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 22
Asp Ile Gln Asn Pro Asp Pro Ala Val Tyr Gln Leu Arg Asp Ser Lys 
1               5                   10                  15      


Ser Ser Asp Lys Ser Val Cys Leu Phe Thr Asp Phe Asp Ser Gln Thr 
            20                  25                  30          


Asn Val Ser Gln Ser Lys Asp Ser Asp Val Tyr Ile Thr Asp Lys Thr 
        35                  40                  45              


Val Leu Asp Met Arg Ser Met Asp Phe Lys Ser Asn Ser Ala Val Ala 
    50                  55                  60                  


Trp Ser Asn Lys Ser Asp Phe Ala Cys Ala Asn Ala Phe Asn Asn Ser 
65                  70                  75                  80  


Ile Ile Pro Glu Asp Thr Phe Phe Pro Ser Pro Glu Ser Ser Cys Asp 
                85                  90                  95      


Val Lys Leu Val Glu Lys Ser Phe Glu Thr Asp Thr Asn Leu Asn Phe 
            100                 105                 110         


Gln Asn Leu Ser Val Ile Gly Phe Arg Ile Leu Leu Leu Lys Val Ala 
        115                 120                 125             


Gly Phe Asn Leu Leu Met Thr Leu Arg Leu Trp Ser Ser 
    130                 135                 140     


<210> 23
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 23
Thr Thr Leu Ser Asn 
1               5   


<210> 24
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 24
Leu Val Lys Ser Gly Glu Val 
1               5           


<210> 25
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 25
Ala Val Gly Ser Met Asp Ser Asn Tyr Gln Leu Ile 
1               5                   10          


<210> 26
<211> 311
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 26
Met Ser Leu Gly Leu Leu Cys Cys Gly Ala Phe Ser Leu Leu Trp Ala 
1               5                   10                  15      


Gly Pro Val Asn Ala Gly Val Thr Gln Thr Pro Lys Phe Arg Val Leu 
            20                  25                  30          


Lys Thr Gly Gln Ser Met Thr Leu Leu Cys Ala Gln Asp Met Asn His 
        35                  40                  45              


Glu Tyr Met Tyr Trp Tyr Arg Gln Asp Pro Gly Met Gly Leu Arg Leu 
    50                  55                  60                  


Ile His Tyr Ser Val Gly Glu Gly Thr Thr Ala Lys Gly Glu Val Pro 
65                  70                  75                  80  


Asp Gly Tyr Asn Val Ser Arg Leu Lys Lys Gln Asn Phe Leu Leu Gly 
                85                  90                  95      


Leu Glu Ser Ala Ala Pro Ser Gln Thr Ser Val Tyr Phe Cys Ala Ser 
            100                 105                 110         


Ser Gln Glu Arg Thr Trp Pro Tyr Asn Glu Gln Phe Phe Gly Pro Gly 
        115                 120                 125             


Thr Arg Leu Thr Val Leu Glu Asp Leu Lys Asn Val Phe Pro Pro Glu 
    130                 135                 140                 


Val Ala Val Phe Glu Pro Ser Glu Ala Glu Ile Ser His Thr Gln Lys 
145                 150                 155                 160 


Ala Thr Leu Val Cys Leu Ala Thr Gly Phe Phe Pro Asp His Val Glu 
                165                 170                 175     


Leu Ser Trp Trp Val Asn Gly Lys Glu Val His Ser Gly Val Ser Thr 
            180                 185                 190         


Asp Pro Gln Pro Leu Lys Glu Gln Pro Ala Leu Asn Asp Ser Arg Tyr 
        195                 200                 205             


Cys Leu Ser Ser Arg Leu Arg Val Ser Ala Thr Phe Trp Gln Asn Pro 
    210                 215                 220                 


Arg Asn His Phe Arg Cys Gln Val Gln Phe Tyr Gly Leu Ser Glu Asn 
225                 230                 235                 240 


Asp Glu Trp Thr Gln Asp Arg Ala Lys Pro Val Thr Gln Ile Val Ser 
                245                 250                 255     


Ala Glu Ala Trp Gly Arg Ala Asp Cys Gly Phe Thr Ser Val Ser Tyr 
            260                 265                 270         


Gln Gln Gly Val Leu Ser Ala Thr Ile Leu Tyr Glu Ile Leu Leu Gly 
        275                 280                 285             


Lys Ala Thr Leu Tyr Ala Val Leu Val Ser Ala Leu Val Leu Met Ala 
    290                 295                 300                 


Met Val Lys Arg Lys Asp Phe 
305                 310     


<210> 27
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 27
Met Ser Leu Gly Leu Leu Cys Cys Gly Ala Phe Ser Leu Leu Trp Ala 
1               5                   10                  15      


Gly Pro Val 
            


<210> 28
<211> 115
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 28
Asn Ala Gly Val Thr Gln Thr Pro Lys Phe Arg Val Leu Lys Thr Gly 
1               5                   10                  15      


Gln Ser Met Thr Leu Leu Cys Ala Gln Asp Met Asn His Glu Tyr Met 
            20                  25                  30          


Tyr Trp Tyr Arg Gln Asp Pro Gly Met Gly Leu Arg Leu Ile His Tyr 
        35                  40                  45              


Ser Val Gly Glu Gly Thr Thr Ala Lys Gly Glu Val Pro Asp Gly Tyr 
    50                  55                  60                  


Asn Val Ser Arg Leu Lys Lys Gln Asn Phe Leu Leu Gly Leu Glu Ser 
65                  70                  75                  80  


Ala Ala Pro Ser Gln Thr Ser Val Tyr Phe Cys Ala Ser Ser Gln Glu 
                85                  90                  95      


Arg Thr Trp Pro Tyr Asn Glu Gln Phe Phe Gly Pro Gly Thr Arg Leu 
            100                 105                 110         


Thr Val Leu 
        115 


<210> 29
<211> 177
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 29
Glu Asp Leu Lys Asn Val Phe Pro Pro Glu Val Ala Val Phe Glu Pro 
1               5                   10                  15      


Ser Glu Ala Glu Ile Ser His Thr Gln Lys Ala Thr Leu Val Cys Leu 
            20                  25                  30          


Ala Thr Gly Phe Phe Pro Asp His Val Glu Leu Ser Trp Trp Val Asn 
        35                  40                  45              


Gly Lys Glu Val His Ser Gly Val Ser Thr Asp Pro Gln Pro Leu Lys 
    50                  55                  60                  


Glu Gln Pro Ala Leu Asn Asp Ser Arg Tyr Cys Leu Ser Ser Arg Leu 
65                  70                  75                  80  


Arg Val Ser Ala Thr Phe Trp Gln Asn Pro Arg Asn His Phe Arg Cys 
                85                  90                  95      


Gln Val Gln Phe Tyr Gly Leu Ser Glu Asn Asp Glu Trp Thr Gln Asp 
            100                 105                 110         


Arg Ala Lys Pro Val Thr Gln Ile Val Ser Ala Glu Ala Trp Gly Arg 
        115                 120                 125             


Ala Asp Cys Gly Phe Thr Ser Val Ser Tyr Gln Gln Gly Val Leu Ser 
    130                 135                 140                 


Ala Thr Ile Leu Tyr Glu Ile Leu Leu Gly Lys Ala Thr Leu Tyr Ala 
145                 150                 155                 160 


Val Leu Val Ser Ala Leu Val Leu Met Ala Met Val Lys Arg Lys Asp 
                165                 170                 175     


Phe 
    


<210> 30
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 30
Ala Ser Ser Gln Glu Arg Thr Trp Pro Tyr Asn Glu Gln Phe 
1               5                   10                  


<210> 31
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 31
Cys Leu Val Val Glu Gly Asn Arg Asp Asp Lys Ile Ile Phe 
1               5                   10                  


<210> 32
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 32
Cys Ala Val Gly Ser Met Asp Ser Asn Tyr Gln Leu Ile Trp 
1               5                   10                  


<210> 33
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 33
Cys Ala Ser Pro Pro Thr Pro Ser Ser Tyr Asn Glu Gln Phe Phe 
1               5                   10                  15  


<210> 34
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 34
Cys Ala Ser Ser Gln Glu Arg Thr Trp Pro Tyr Asn Glu Gln Phe Phe 
1               5                   10                  15      


<210> 35
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 35
Gly Val Tyr Asp Gly Arg Glu His Thr Val 
1               5                   10  


<210> 36
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 36
Lys Val Leu Glu His Val Val Arg Val 
1               5                   


